Directive on Grievance Redress Mechanisms

  • Version
  • Download 479
  • File Size 664.42 KB
  • File Count 1
  • Create Date 17 February 2024
  • Last Updated 17 February 2024

Directive on Grievance Redress Mechanisms

Introduction

1. A significant component of Africa CDC’s work is undertaken through projects implemented directly by Africa CDC or through Implementing, Partners.  While the objectives of projects are aimed at producing positive impacts, they may also  give rise to uncertainties, unintended consequences or actions not compliant with Africa CDC policies.  A grievance redress mechanism (GRM) is a set of arrangements that enable any affected stakeholders to seek information, raise concerns or report grievances concerning projects and to seek redress when they perceive a negative impact has arisen from the project activities. This directive focuses on those communications which are grievances.

2. As illustrated in the simple overview below, GRMs come in different forms.  In all cases, Africa CDC’s Institutional GRM is available to receive grievances from stakeholders for all Africa CDC projects and activities.  Depending on the particular characteristics of a project, this may be supplemented by an Implementing Partner’s own Institutional GRM if that exists, or by project-specific GRMs which may be tailored specifically to the project’s scope, structure and risks and may incorporate existing local or community dispute resolution mechanisms.

Attached Files

FileAction
Directive on Grievance Redress MechanismsDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload